glp-1 and family history of thyroid cancer The Twist: How Agonists Are Influencing Autoimmune Thyroid Care Implications of GLP-1 Receptor Agonist

This framework generates testable predictions and potential monitoring endpointsincluding lean mass trajectory, micronutrient status, fat-soluble vitamin surveillance, and exploratory redox-related biomarkersthat can be evaluated in future longitudinal and interventional studies

the needles on the injection pens are so thin and short that they wont go very deep

More than expected

Bone fractures Small increased fracture risk and changes in bone mineral density (BMD) seen in those treated with canagliflozin compared with placebo in the CANVAS (but not CANVAS-R or CREDENCE) trial, and with ertugliflozin, but not identified in empagliflozin or dapagliflozin studies